|Articles|September 17, 0001
Side effects preclude thalidomide usefulness for AMD
Philadelphia-Thalidomide is dead, at least when it comes to itscurative properties for age-related macular degeneration (AMD). This isthe conclusion of the Age-Related Macular Degeneration and Thalidomide Study(AMDATS).
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
























